Annual Current Ratio
51.59
+41.61+416.93%
31 December 2023
Summary:
MoonLake Immunotherapeutics annual current ratio is currently 51.59, with the most recent change of +41.61 (+416.93%) on 31 December 2023. MLTX annual current ratio is now at all-time high.MLTX Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
25.51
-18.20-41.64%
30 September 2024
Summary:
MoonLake Immunotherapeutics quarterly current ratio is currently 25.51, with the most recent change of -18.20 (-41.64%) on 30 September 2024. Over the past year, it has dropped by -23.00 (-47.41%). MLTX quarterly current ratio is now -64.06% below its all-time high of 70.97, reached on 30 June 2023.MLTX Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +416.9% | -47.4% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MLTX Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -64.1% | +5445.6% |
| 5 y | 5 years | at high | >+9999.0% | -64.1% | +5445.6% |
| alltime | all time | at high | >+9999.0% | -64.1% | +5445.6% |
MoonLake Immunotherapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 25.51(-41.6%) |
| June 2024 | - | 43.71(-29.6%) |
| Mar 2024 | - | 62.13(+20.4%) |
| Dec 2023 | 51.59 | 51.59(+6.3%) |
| Sept 2023 | - | 48.51(-31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | 70.97(+676.5%) |
| Mar 2023 | - | 9.14(-8.4%) |
| Dec 2022 | 9.98(+2069.6%) | 9.98(-32.2%) |
| Sept 2022 | - | 14.71(-42.3%) |
| June 2022 | - | 25.51(+5445.7%) |
| Dec 2021 | 0.46 | 0.46 |
FAQ
- What is MoonLake Immunotherapeutics annual current ratio?
- What is the all time high annual current ratio for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual current ratio year-on-year change?
- What is MoonLake Immunotherapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly current ratio year-on-year change?
What is MoonLake Immunotherapeutics annual current ratio?
The current annual current ratio of MLTX is 51.59
What is the all time high annual current ratio for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual current ratio is 51.59
What is MoonLake Immunotherapeutics annual current ratio year-on-year change?
Over the past year, MLTX annual current ratio has changed by +41.61 (+416.93%)
What is MoonLake Immunotherapeutics quarterly current ratio?
The current quarterly current ratio of MLTX is 25.51
What is the all time high quarterly current ratio for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly current ratio is 70.97
What is MoonLake Immunotherapeutics quarterly current ratio year-on-year change?
Over the past year, MLTX quarterly current ratio has changed by -23.00 (-47.41%)